Assenagon Asset Management’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $105K | Sell |
31,125
-5,792
| -16% | -$19.5K | ﹤0.01% | 1113 |
|
|
2025
Q1 | $143K | Sell |
36,917
-19,700
| -35% | -$76K | ﹤0.01% | 1105 |
|
|
2024
Q4 | $349K | Sell |
56,617
-289,575
| -84% | -$1.79M | ﹤0.01% | 1208 |
|
|
2024
Q3 | $1.86M | Sell |
346,192
-1,602
| -0.5% | -$8.62K | ﹤0.01% | 964 |
|
|
2024
Q2 | $1.17M | Hold |
347,794
| – | – | ﹤0.01% | 1037 |
|
|
2024
Q1 | $1.4M | Buy |
347,794
+102,567
| +42% | +$413K | ﹤0.01% | 955 |
|
|
2023
Q4 | $650K | Sell |
245,227
-2,820
| -1% | -$7.47K | ﹤0.01% | 1154 |
|
|
2023
Q3 | $585K | Sell |
248,047
-53,641
| -18% | -$127K | ﹤0.01% | 1126 |
|
|
2023
Q2 | $1.9M | Buy |
301,688
+133,473
| +79% | +$841K | 0.01% | 772 |
|
|
2023
Q1 | $971K | Buy |
+168,215
| New | +$971K | ﹤0.01% | 1027 |
|